We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B Turnover 41.06%
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
+9.41%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.93B
AUM Growth
+$1.08B
Cap. Flow
+$347M
Cap. Flow %
17.97%
Top 10 Hldgs %
58.78%
Holding
104
New
42
Increased
25
Reduced
17
Closed
19
Avg Time Held Equity + Options
0.6 years
Top 10 Avg Time Held Equity + Options
0.3 years
Top 20 Avg Time Held Equity + Options
0.6 years
Avg Time Held Equity only
0.6 years
Top 10 Avg Time Held Equity only
0.6 years
Top 20 Avg Time Held Equity only
0.7 years

Top Buys

Rank Stock Value
1
ARKG icon
ARK Genomic Revolution ETF
ARKG
+$80M
2
XLRN
Acceleron Pharma
XLRN
+$31.3M
3
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
+$24.2M
4
CYH icon
Community Health Systems
CYH
+$23.5M
5
MCK icon
McKesson
MCK
+$22.4M

Top Sells

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$23.6M
2
ENSG icon
The Ensign Group
ENSG
+$15.4M
3
CTLT icon
CATALENT, INC.
CTLT
+$13M
4
HSKA
Heska Corp
HSKA
+$11.5M
5
RAD
Rite Aid Corporation
RAD
+$10.4M

Sector Composition

Rank Sector Weight
1 Healthcare 58.91%
2 Miscellaneous 40.99%
3 Consumer Discretionary 0.06%
4 Financials 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CNCE
101
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-103,829
Closed -$1.31M –
LCI
102
CALL
DELISTED
Lannett Company, Inc.
LCI
– –
-15,975
Closed -$354K –
OTIC
103
DELISTED
Otonomy, Inc.
OTIC
– –
-253,283
Closed -$1.04M –
OXFD
104
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
– –
-307,742
Closed -$5.37M –
1 2 3 4
5

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return

Eversept Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Eversept Partners held 104 positions worth $1.93B, up 126% from $852M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Eversept Partners deployed $347M of net new capital in Q1 2021, opening 42 new positions and adding to 25 existing holdings. Its largest new stake was ARK Genomic Revolution ETF: 806,932 shares worth $71.6M.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, down from 98% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

On the sell side, the largest reduction was The Ensign Group, an estimated $15.4M trimmed.

  • Eversept Partners's largest Q1 2021 buy was ARK Genomic Revolution ETF: 806,932 shares worth $71.6M.
  • Eversept Partners added most to Community Health Systems in Q1 2021, an estimated $23.5M increase.
  • Eversept Partners's biggest Q1 2021 reduction was The Ensign Group, cutting an estimated $15.4M.
  • Eversept Partners fully exited Sarepta Therapeutics in Q1 2021, selling an estimated $23.6M.
  • Eversept Partners's ten largest holdings make up 59% of its $1.93B portfolio in Q1 2021.
  • Eversept Partners opened 42 new positions and closed 19 in Q1 2021.
  • Eversept Partners's portfolio value rose 126% quarter-over-quarter to $1.93B.

Based on Eversept Partners's 13F filing for Q1 2021, filed 13 May 2021.